HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tirone E. David Gheorghe Gavra Christopher M. Feindel Tommaso Regesta Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by David, T. E. Articles by Maganti, M. D. Search for Related Content PubMed PubMed Citation Articles by David, T. E. Articles by Maganti, M. D. Related Collections Related Article

J Thorac Cardiovasc Surg 2007;133:144-149
© 2007 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Surgical treatment of active infective endocarditis: A continued challenge

Division of Cardiovascular Surgery of Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada.

Read at the Thirty-second Annual Meeting of the Western Thoracic Surgical Association, Sun Valley, Idaho, June 21-24, 2006.

Received for publication June 14, 2006; revisions received August 6, 2006; accepted for publication August 25, 2006.

^_* Address for reprints: Tirone E. David, MD, 200 Elizabeth St, 4N-457, Toronto, Ontario M5G 2C4, Canada. (Email: tirone.david{at}uhn.on.ca).

OBJECTIVE: This study was undertaken to examine the outcomes of surgery for active infective endocarditis in a large cohort of patients.

METHODS: Three hundred eighty-three consecutive patients underwent surgery for active infective endocarditis. The mean age was 51 ± 16 years, and 64% were men. The infected valve was native in 266 patients and prosthetic in 117. Staphylococcus aureus was the most common microorganism. Surgery consisted of valve replacement or repair in patients with infection limited to the cusps or leaflets of the valve or radical resection of seemingly infected paravalvular tissues, and reconstruction with patches and valve replacement in patients with abscess (135 patients). The mean follow-up was 6.1 ± 5.2 years.

RESULTS: There were 45 (12%) operative and 88 (23%) late deaths. The operative mortality did not change during the period of study. Preoperative shock, prosthetic valve endocarditis, paravalvular abscess, and S aureus were independent predictors of operative mortality. Age, shock, prosthetic valve endocarditis, left ventricular ejection fraction less than 40%, and recurrent endocarditis were independent predictors of death from all causes. Survivals at 15 years were 44% ± 5% overall, 59% ± 5% for native valve endocarditis, and 25% ± 7% for prosthetic valve endocarditis (P = .001). Freedom from recurrent endocarditis at 15 years was 86% ± 3% for all patients, similar to those for native and prosthetic valve endocarditis (P = .39). Freedom from reoperation at 15 years was 70% ± 6% for all patients, similar to those for native and prosthetic valve endocarditis (P = .55).

CONCLUSIONS: Surgery for endocarditis continues to be challenging and associated with high operative mortality and morbidity. Age, shock, prosthetic valve endocarditis, impaired ventricular function, and recurrent infections adversely affect long-term survival.

Related Article

Discussion
J. Thorac. Cardiovasc. Surg. 2007 133: 149. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				E. Shang, G. N. Forrest, T. Chizmar, J. Chim, J. M. Brown, M. Zhan, G. H. Zoarski, B. P. Griffith, and J. S. Gammie Mitral Valve Infective Endocarditis: Benefit of Early Operation and Aggressive Use of Repair. Ann. Thorac. Surg., June 1, 2009; 87(6): 1728 - 1734. [Abstract] [Full Text] [PDF]

				S. Lehmann, T. Walther, S. Leontyev, J. Kempfert, J. Garbade, M. A. Borger, and F. W. Mohr The Toronto Root Bioprosthesis: Midterm Results in 186 Patients. Ann. Thorac. Surg., June 1, 2009; 87(6): 1751 - 1756. [Abstract] [Full Text] [PDF]

				F. Yao, L. Han, Z.-y. Xu, L.-j. Zou, S.-d. Huang, Z.-n. Wang, F.-l. Lu, and Y.-l. Yao Surgical treatment of multivalvular endocarditis: Twenty-one-year single center experience. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1475 - 1480. [Abstract] [Full Text] [PDF]

				F. Thuny, S. Beurtheret, J. Mancini, V. Gariboldi, J.-P. Casalta, A. Riberi, R. Giorgi, F. Gouriet, L. Tafanelli, J.-F. Avierinos, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis Eur. Heart J., March 26, 2009; (2009) ehp089v1. [Abstract] [Full Text] [PDF]

				A. Marui, K. Hirose, H. Sakaguchi, Y. Arai, K. Doi, M. Tsukashita, T. Shimamoto, T. Ikeda, and M. Komeda A potential of autologous pericardium for a sustained-release carrier of vancomycin: a pilot study in vitro. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 783 - 784. [Full Text] [PDF]

				J. P. Remadi, G. Nadji, T. Goissen, N. A. Zomvuama, C. Sorel, and C. Tribouilloy Infective endocarditis in elderly patients: clinical characteristics and outcome Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 123 - 129. [Abstract] [Full Text] [PDF]

				A. M. Sheikh, A. M. Elhenawy, M. Maganti, S. Armstrong, T. E. David, and C. M. Feindel Outcomes of surgical intervention for isolated active mitral valve endocarditis. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 110 - 116. [Abstract] [Full Text] [PDF]

				S. H. Rahimtoola The Year in Valvular Heart Disease. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 760 - 770. [Full Text] [PDF]

				J.-F. Avierinos, F. Thuny, V. Chalvignac, R. Giorgi, L. Tafanelli, J.-P. Casalta, D. Raoult, T. Mesana, F. Collart, D. Metras, et al. Surgical Treatment of Active Aortic Endocarditis: Homografts Are Not the Cornerstone of Outcome Ann. Thorac. Surg., December 1, 2007; 84(6): 1935 - 1942. [Abstract] [Full Text] [PDF]